Category: Uncategorized

Health Innovation Hub Ireland and Irish Platform for Patient Organisations, Science & Industry (IPPOSI) announce new Memorandum of Understanding

  |   By  |  0 Comments

Health Innovation Hub Ireland and IPPOSI (Irish Platform for Patient Organisations, Science & Industry) IPPOSI announce new Memorandum of Understanding

Health Innovation Hub Ireland (HIHI) is pleased to announce a Memorandum of Understanding (MoU) with IPPOSI. The MoU is of  mutual interest to IPPOSI and HIHI with regard to healthcare innovation, patient care and empowerment in Ireland. This MoU will establish a closer working relationship to maximise IPPOSI and HIHI offerings.

The commitments in the MoU cover three areas: representation, education and patient empowerment.

HIHI National Director Colman Casey said:

“Patient’s interests and viewpoints are crucial to HIHI in how we operate and deliver for both Irish healthcare and Irish health companies. This formal working agreement with IPPOSI will strengthen this.

“The MoU covers patient involvement in the HIHI Steering Committee, judging in the competitive pitch process of annual call to industry, mutual support for our respective education programmes and a joint commitment to patient empowerment in health innovation.”

Ava Battles, Chair of IPPOSI said:

“We are very pleased to sign a memorandum of understanding with HIHI and look forward to collaborating with them to strengthen the voice of patients at the heart of their work.

“We will facilitate the establishment of patient representation in HIHI, and through our working more closely together, we will maximise the impact of our respective education programmes.”

The HIHI and IPPOSI MoU is for an initial two-year period from February 1 2019.

(For further information: HIHI Dublin Manager, Eimear Galvin –



Advising Life Sciences Seminar: the opportunities for business

   |   By  |  0 Comments

The European Investment Bank, Ibec & the Irish Medtech Association would like to invite you to

 Advising Life Sciences Seminar: the opportunities for business

 Date: Friday, 8 March 2018

Time: 08:30-10:30

Venue: Clayton Hotel, Galway

Register on below link,-ibec-and-ima-advising-life-sciences-seminar-08-03-2019?OpenDocument

Andrew McDowell, Vice President of the European Investment Bank, in conjunction with Ibec and the Irish Medtech Association, would like to cordially invite you to a special life-sciences round-table in Galway. This event will be of particular interest to corporate finance teams advising clients companies located in Ireland, as well as those working with high growth start-ups.

This is a tailored session inform firms about the potential offering of the EIB corporate lending in life-sciences. It will allow attendees to gain greater insights into what supports the EIB can offer to Irish and Irish-based companies. It will also be an opportunity to engage directly with senior representatives of the EIB corporate lending team.

EIB Speakers include;

  • Andrew McDowell,  Vice President, EIB
  • Auvo Kaikonnen, Senior LifeSciences Specialist, EIB
  • Michael Finucane, Dictorate for Lending Operations, EIB
  • Stefano Marzario,  Investment Officer, EIB

The EIB is the world’s largest international public bank and the bank of the European Union. The EIB does not just provide infrastructure, it is a leading source of finance for business. It has a range of products that Irish companies can access directly.


Besides an overview of the bank and the products available, this event will also feature a discussion with Aerogen CEO, John Power to understand their experience of working with the bank and what this relationship has meant for their business. Please confirm your attendance to via the following link:,-ibec-and-ima-advising-life-sciences-seminar-08-03-2019?OpenDocument


HIHI’s third Workshop 1 concludes in Cork, with groups now amalgamating for Q2’s Workshop 2

  |   By  |  0 Comments

Opened by Professor Geraldine McCarthy, Chairperson of the South/Southwest Hospital Group, an enthusiastic bunch converged on the Western Gateway Building , UCC, Cork, for the final run of HIHI’s Workshop 1 – Rethinking Healthcare Innovation. The group, as with both Dublin and Galway, reflected the wide appetite for this programme with all levels, clinical and non clinical, administrative and support workers among the attendees.

Health Innovation Hub Ireland’s free workshop programme is designed for HSE and voluntary hospital staff. Attendance at Workshop 1 is mandatory as the programme is designed on a continuum learning basis. Next up is Workshop 2 – Design Thinking in Healthcare Innovation, which will run later in Q2.

Having already completed Workshop 1 in Dublin last November, Galway earlier this month and Cork today, all cohorts will now be combined to continue the workshop programme for 2019, as one group.

If you are interested in hearing more and keeping up to date with opportunities please email – Eimear Galvin, Manager HIHI Dublin –

It@cork’s March Tech Talk ‘Grand Challenges for LifeScience and Healthcare’: exploring opportunities for the IT Industry

  |   By  |  0 Comments

The March Tech Talk event will take place on 5th March in The Kingsley Hotel Cork and will focus on People, Process, Technology and Data in the health ecosystem.

IT plays a critical role in driving this change. This IT@Cork session brings together speakers from all aspects of the healthtech sector to discuss and explore current and future opportunities.

Click here for more information and registration


Minister for Health secures Government approval to create national research ethics committee

   |   By  |  0 Comments

The Government has approved proposals by Minister for Health Simon Harris TD to prepare a General Scheme of a Bill to provide for national research ethics committees.

Speaking today (Thursday), Minister Harris said “Health research is essential to deliver the best care and treatment for our patients, better value for our health spending and more high-quality jobs for our workforce.  Supporting health research is a key part of the Sláintecare programme”.

The Minister added: “Research ethics committees (RECs) are key in ensuring that health research is carried out to the ethical standards expected by society, and we need to support a national system of research ethics committees that is fit for purpose.  The new National REC system will ensure that there is public confidence in how health research is being conducted, especially in new and emerging areas of research”.

Innovation 2020, Ireland’s strategy for research and development, science and technology , aims to make Ireland a global leader in research and innovation and the Government is committed to the ongoing development of a quality focussed research-active health system in Ireland.  That commitment has already seen major public investment in research infrastructure, personnel, new skills and technology.  Over the last decade, there has been more than €150 million Government funding invested in clinical research and clinical trials infrastructure through the Health Research Board (HRB) alone.  There has also been significant investment from State bodies, like Science Foundation Ireland, voluntary organisations and the private sector.

The proposed new system will address concerns that have been raised by stakeholders over the last decade about the existing RECs system in Ireland for clinical trials and health research generally. This approach will maximise synergies and value-for-money outcomes and make Ireland a more attractive international location for all health research.

Welcoming the Minister’s initiative, the CEO of the Health Research Board, Darrin Morrissey, said “The establishment of a single, cohesive national Research Ethics Committee structure in Ireland is long overdue.  It will help grow health research and clinical trial activity that will benefit people’s health and patient care, as well as underpinning health innovation and economic growth in Ireland.”

The HPRA also welcomed the Bill saying “The HPRA supports further development of the National Ethics Committee framework as a key part of the infrastructure required for active health research and clinical trials in Ireland and to align to future changes in the regulatory requirements for European clinical trials.”

The Bill is regarded as a priority and the Department will work closely with stakeholders, including the Health Research Board and the Health Products Regulatory Authority to have a Bill published by the end of the year.

In the context of the preparation of the General Scheme, the Department will engage with a broad range of stakeholders including other Departments, agencies, institutional RECs, researchers, industry and patients to seek their views on specific matters.

Irish Cancer Society is now accepting Expression of Interest applications for the 2019 Research Scholarship Programmes

   |   By  |  0 Comments

We are pleased to announce that the Irish Cancer Society is now accepting Expression of Interest applications for the 2019 Research Scholarship Programmes: Biomedical Research Scholarship and Social and Allied Health Science Research Scholarship.

Applications can be made through the Irish Cancer Society Online Grant System.

Deadline for Expression of Interest applications: 3pm Tuesday 26th February 2019.